Biovis Abilicy South San Francisco, CA - 94080

Biovis Abilicy is categorized under Research and Development Laboratories in South San Francisco, CA and active since 2006.

Biovis Abilicy was established in 2006, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Kate Gunning at the company’s single location by writing to 400 Oyster Point Boulevard, South San Francisco, California CA 94080 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Biovis Abilicy
Contact Person: Kate Gunning
Address: 400 Oyster Point Boulevard, South San Francisco, California 94080
Website Address: biovisability.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2006
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Biovis Abilicy was started in 2006 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Kate Gunning for inquiries that concern Biovis Abilicy by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Biovis Abilicy can be found at the coordinates as well as the street address 400 Oyster Point Boulevard in South San Francisco, California 94080.

For its online presence, you may visit Biovis Abilicy’s website at biovisability.com and engage with its social media outlets through on Twitter and on Facebook.